Similar articles

• Patents on breast cancer genes are illegal and stymie research, say scientists.

  Lenzer J. Lenzer J. BMJ. 2009 Nov 17;339:b4899. doi: 10.1136/bmj.b4899. BMJ. 2009. PMID: 19920010 No abstract available.
• ACLU lawsuit questions the patenting of breast cancer genes.

  Printz C. Printz C. Cancer. 2009 Nov 1;115(21):4887-8. doi: 10.1002/cncr.24706. Cancer. 2009. PMID: 19842208 No abstract available.
• US Supreme Court is asked to rule on validity of patents on BRCA1 and BRCA2 genes.

  Dyer C. Dyer C. BMJ. 2012 Oct 2;345:e6624. doi: 10.1136/bmj.e6624. BMJ. 2012. PMID: 23033368 No abstract available.
• The European opposition against the BRCA gene patents.

  Matthijs G. Matthijs G. Fam Cancer. 2006;5(1):95-102. doi: 10.1007/s10689-005-2580-6. Fam Cancer. 2006. PMID: 16528613 Review.
• BRCA1 and BRCA2: 1994 and beyond.

  Narod SA, Foulkes WD. Narod SA, et al. Nat Rev Cancer. 2004 Sep;4(9):665-76. doi: 10.1038/nrc1431. Nat Rev Cancer. 2004. PMID: 15343273 Review.